Stock Track | PA GOODDOCTOR Soars 12.96% Intraday on Strong 2025 Earnings Beat and Citigroup Buy Rating

Stock Track03-25

PA GOODDOCTOR's stock price surged 12.96% during intraday trading on Wednesday, following the release of its impressive 2025 financial results and a bullish analyst report.

The company reported a significant year-on-year increase in both revenue and net profit for 2025, with earnings substantially exceeding market expectations. This strong performance, coupled with improved profit margins driven by AI initiatives and efficiency management, provided a fundamental catalyst for the sharp price appreciation.

Adding to the positive sentiment, Citigroup issued a research report affirming a "Buy" rating on the stock and setting a target price of HK$18, citing the earnings beat and the company's strengthened financial profile.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment